207 related articles for article (PubMed ID: 15297443)
1. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
2. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
3. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.
Prisco M; Maiorana A; Guerzoni C; Calin G; Calabretta B; Voit R; Grummt I; Baserga R
Mol Cell Biol; 2004 Jun; 24(12):5421-33. PubMed ID: 15169904
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
Sun H; Tu X; Baserga R
Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
[TBL] [Abstract][Full Text] [Related]
5. The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin.
Yenush L; Zanella C; Uchida T; Bernal D; White MF
Mol Cell Biol; 1998 Nov; 18(11):6784-94. PubMed ID: 9774692
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.
Navarro M; Valentinis B; Belletti B; Romano G; Reiss K; Baserga R
Endocrinology; 2001 Dec; 142(12):5149-57. PubMed ID: 11713209
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells.
Shi B; Prisco M; Calin G; Liu CG; Russo G; Giordano A; Baserga R
J Cell Physiol; 2006 Jun; 207(3):706-10. PubMed ID: 16482530
[TBL] [Abstract][Full Text] [Related]
8. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.
Valentinis B; Navarro M; Zanocco-Marani T; Edmonds P; McCormick J; Morrione A; Sacchi A; Romano G; Reiss K; Baserga R
J Biol Chem; 2000 Aug; 275(33):25451-9. PubMed ID: 10846175
[TBL] [Abstract][Full Text] [Related]
10. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
[TBL] [Abstract][Full Text] [Related]
12. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
[TBL] [Abstract][Full Text] [Related]
17. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
18. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
20. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
